Summary
Transtympanic administration of gentamicin was used to treat patients with unilateral Menière's disease and was stopped at the first signs of damage to cochlear and/or vestibular function. Twenty-eight patients were treated between 1974 and 1981 and 34 patients were managed between 1981 and 1987. In the two groups of patients, objective vertigo disappeared in 85%, hearing improved in 26%, aural fullness disappeared in 78%, while tinnitus ceased altogether in 51% and became less intense in 24%. Our findings show that this kind of treatment can be used after unsuccessful medical therapy and prior to any labyrinthine or endolymphatic sac surgery.
Similar content being viewed by others
References
Arslan M (1978) A new hypothesis on the plurifocal etiology of Menière's disease. Acta Otolaryngol (Stockh) 86 [Suppl 357]:1–19
Beck C (1985) Intratympanic application of gentamicin for treatment of Menière's disease. Kejo J Med 35:36–41
Beck C, Schmidt C (1978) 10 years of experience with intratympanically applied streptomicin (gentamycin) in the therapy of morbus Menière. Arch Ital Oto-Rhino-Laryngol 221:149–152
Catalano GB, Conticello S, Serra A (1983) Modificazioni ultrastrutturali degli otoliti nella intossicazione cronica da aminoglicosidi. Acta Oto-Rhino-Laryngol Ital 3:373–380
De Vincentiis I, Ralli G (1980) Nuovi orientamenti sulla patogenesi e terapia della malattia di Menière. Attualità in Otorinolaringologia. Valeas, Milano, pp 105–112
Doley E, Tamir A, Leventon G (1983) Is magnesium depletion the reason for ototoxicity caused by aminoglycosides? Med Hypotheses 10:353–358
Federspil P (1984) Ototoxicität Grenzdosen. HNO 32:417–418
Feldbaum JS, Silverstein H (1984) Streptomycin drug fever during treatment of bilateral Menière's disease. Arch Otolaryngol 110:538–539
Forge A, Fradis M (1985) Structural abnormalities in the stria vascularis following chronic gentamicin treatment. Hear Res 20:223–224
Gavilan J, Gavilan C (1984) Middle fossa vestibular neurectomy. Long-term results. Arch Otolaryngol 110:785–787
Graham MD, Sataloff RT, Kemink JL (1984) Tinnitus in Menière's disease: response to titration streptomycin therapy. J Laryngol Otol 98:281–286
Hayashida T, Nomura Y, Iwamori M, Nagai Y, Kurata T (1985) Distribution of gentamicin by immunofluorescence in the guinea pig inner ear. Arch Otorhinolaryngol 242:257–264
House JW (1981) Panel on tinnitus control. Management of the tinnitus patient. Ann Otol 90:597–601
Huizing EH, Kuper-Carriere EJG, Tange RA (1985) Results of clinical, electrophysiological and histological investigations of gentamycin ototoxicity. Riv Ital ORL Aud Fon 5:67–73
Lange G (1977) Die intratympanale Behandlung des Morbus Menière mit ototoxischen Antibiotica. Arch Laryngol Rhinol Otol 56:409–414
Lange G (1981) Die Indikation zur intratympanale Gentamycin-Behandlung der Menièreschen Krankheit. HNO 29:49–51
Lange G (1985) Technische Schwierigkeiten bei der intratympanale Gentamycin-Therapie des Morbus Menière. Laryngol Rhinol Otol 64:174
Lee SJ, Harpur ES (1984) Acute effects of gentamycin and furosemide on guinea pig cochlear potentials. Br J Audiol 18:245–259
Marullo T, Filipo R, Fabiani M (1980) Il problema terapeutico della malattia di Menière. Attualità in otorinolaringologia. Valeas, Milan, pp 157–179
Morgenstern C, Ninoyu O, Mori N, Mertens HP (1986) Zur Wirkung von Aminoglycosides auf den experimentell erzeugten endolymphatischen Hydrops. Laryngol Rhinol Otol 65:371–373
Motta G, Jengo M (1983) Invited lectures on “tinnitus” at the LXX National Congress of the Italian ENT Society (SIO & Ch C Fac) 25–28 May 1983, Bologna. SIO, Rome
Ohtani I, Ohtsuki K, Aikawa T (1982) Evaluation of ototoxicity of aminoglycoside antibiotic in rabbits. Auris Nasus Larynx 9:67–74
Ottaviani A, Bergomi A (1983) Invited lectures on “tinnitus” at the LXX National Congress of the Italian ENT Society (SIO & Ch C Fac), 25–28 May, Bologna, SIO, Rome
Paparella MM (1984) Pathogenesis of Menière's disease and Menière's syndrome. Acta Otolaryngol (Stockh) [Suppl 406]:10–25
Pappas DG (1984) Diagnostic correlations between tinnitus and Menière's disease as determined by computerized rotary chair. J Laryngol Otol 98 [Suppl 9]:184–187
Pender DJ (1985) Gentamycin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol Head Neck Surg 6:358–367
Sala O (1977) Otorinolaringojatria. In: Roversi AA (ed) Manuale medico di diagnostica e terapia. Gruppo Lepetit, Milan, pp 946–1013
Sala T (1981) Transtympanic administration of gentamycin in the treatment of Menière's disease. Riv Ital ORL Aud Fon 1:209–213
Schuknecht H (1957) Ablation therapy in the management of Menière's disease. Acta Otolaryngol (Stockh) [Suppl 132]:1–42
Schmidt C, Beck C (1980) Behandlung des morbus Menière mit intratympanal applizierten Gentamycin-Sulfat. Laryngol Rhinol 59:804–807
Silverstein H (1984) Streptomycin treatment for Menière's disease. Ann Otol 93 [Suppl 112]:44–48
Silverstein H, Hyman SM, Feldbaum J, Silverstein D (1984) Use of streptomycin sulfate in the treatment of Menière's disease. Am J Otolaryngol Head Neck Surg 92:229–232
Wang BM, Weiner ND, Takada A, Schacht J (1984) Characterization of aminoglycoside-lipid interactions and development of a rifined model for ototoxicity testing. Biochem Pharmacol 33:3257–3262
Williams SE (1987) Characteristics of gentamycin uptake in the isolated crista ampullaris of the inner ear of the guinea pig. Biochem Pharmacol 36:89–95
Zenner HP (1986) K+-induced motility and depolarisation of cochlear hair cells. Direct evidence of a new pathophysiological mechanism in Menière's disease. Arch Otorhinolaryngol 243:108–111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sala, T. Transtympanic administration of aminoglycosides in patients with Menière's disease. Arch Otorhinolaryngol 245, 293–296 (1988). https://doi.org/10.1007/BF00464634
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00464634